for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
A new world is possible.
Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
UK pharma group to commercialise 26 drug targets using technology proven with Covid-19 vaccines
Agency decision to restrict third jabs to vulnerable Americans deals blow to Biden’s strategy
Joe Biden urges other wealthy countries to follow suit in a bid to boost access around the world
Lawyers warn of risk contravening anti-discrimination rules
Asian Development Bank says economic recovery in some countries is being held back by Covid outbreaks
President resisted at first but was convinced reopening border would help US jab campaign
Companies say data provide ‘strong foundation’ to seek authorisation to vaccinate 5-11 age group
Advisory committee endorses third dose only for elderly and at-risk groups in blow to Biden
Chief of Serum Institute criticises ‘unethical’ behaviour of wealthy nations pursuing Covid booster jabs
The UK government’s confused handling of the situation has only fuelled distrust
Not every unvaccinated person believes Covid-19 jabs are a genocidal conspiracy
Requirement would be strictest measure in Europe so far to curtail movement based on vaccination status
Data come as US regulator weighs approval for booster shot to bolster immunity
Several pharma groups are hoping the Covid vaccine race will turn out to be a marathon, not a sprint
Executive signals intention to secure authorisation for infants as young as six months old
Britain is joining nine other countries that have announced similar programmes offering an additional jab
Planned measures would include vaccine passports, mandatory face masks and work-from-home orders